Stay updated on Clinical Trial: Fycompa in Adolescence Epilepsy Patients
Sign up to get notified when there's something new on the Clinical Trial: Fycompa in Adolescence Epilepsy Patients page.

Latest updates to the Clinical Trial: Fycompa in Adolescence Epilepsy Patients page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe study record for long-term Fycompa treatment in adolescents with epilepsy is displayed, including its completed status, eligibility criteria, locations, treatment details, and safety and seizure outcomes.SummaryDifference34%

- Check16 days agoChange DetectedThe footer revision identifier was updated from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check23 days agoChange DetectedA banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check51 days agoChange DetectedThe study page now renders a 403 Forbidden error, replacing the previous content and displaying a standard footer on the error page. This indicates restricted access to the study record rather than the actual study details.SummaryDifference0.5%

Stay in the know with updates to Clinical Trial: Fycompa in Adolescence Epilepsy Patients
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Fycompa in Adolescence Epilepsy Patients page.